+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Flow Cytometry in Oncology & Immunology Market by Product Type (Instruments, Reagents & Consumables), Technology (Conventional Flow Cytometry, Imaging Flow Cytometry, Mass Cytometry), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924942
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Flow Cytometry in Oncology & Immunology Market is positioned for sustained expansion, fueled by robust demand for advanced cellular analysis tools. Senior executives and R&D leaders will find that ongoing technology integration and workflow modernization are accelerating innovation across research and clinical applications.

Market Snapshot: Flow Cytometry in Oncology & Immunology

The global market for flow cytometry within oncology and immunology is witnessing strong growth, expanding from USD 1.18 billion in 2024 to USD 1.30 billion in 2025. It is projected to maintain a healthy CAGR of 9.66%, reaching USD 2.06 billion by 2030. Demand is underpinned by increasing adoption of advanced analyzers and high-throughput sorting platforms, as organizations seek greater depth in single-cell profiling and real-time phenotypic analysis.

Scope & Segmentation

This report delivers a comprehensive assessment of the Flow Cytometry in Oncology & Immunology Market, with a segmentation framework that supports actionable insights for procurement, R&D planning, and market positioning:

  • Product Type: Instruments (including cell analyzers and cell sorters), Reagents & Consumables (comprising calibration beads, tubes, plates, antibodies, and assay kits)
  • Technology: Conventional flow cytometry, multicolor cytometry, imaging flow cytometry, and mass cytometry
  • Application: Cell therapy workflows, clinical diagnostics (immunology and oncology), and fundamental oncology or immunology research
  • End User: Academic institutions, contract research organizations, hospitals, pharmaceutical and biotechnology companies, and research laboratories
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific; including focus markets such as the United States, United Kingdom, Germany, China, India, and others
  • Key Companies Assessed: Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sysmex Corporation, Bio-Rad Laboratories, Agilent Technologies, Miltenyi Biotec, Sony Biotechnology, Cytek Biosciences

Key Takeaways for Senior Decision-Makers

  • Integration of advanced flow cytometry technologies is unlocking new workflows for oncology and immunology, enabling more granular multiparametric analysis and deeper insights into disease mechanisms.
  • Adoption of imaging and mass cytometry platforms is facilitating expansion beyond conventional assays, supporting high-parameter profiling in both translational and clinical research settings.
  • Collaborative partnerships between instrument and reagent providers support workflow optimization, while modular system architectures enable scalable, future-ready infrastructure investments.
  • Artificial intelligence and automation are streamlining data analytics, reducing human variability and boosting throughput and reproducibility in cell population identification.
  • Regional investment patterns indicate tailored adoption strategies, with North America and Europe emphasizing advanced instrument deployments and Asia-Pacific focusing on scalable, accessible analyzer solutions for a growing research base.

Tariff Impact on Procurement & Operations

Revised United States tariff measures effective from 2025 have influenced landed costs for both core instruments and essential reagents. Many organizations responded by re-evaluating supply chain strategies, exploring alternative sourcing channels, and leveraging bundled procurement to manage increased expenses. Strategic collaborations and volume consolidation are helping research institutions and vendors counterbalance tariff-induced cost pressures, underscoring the importance of agile, resilient procurement frameworks for uninterrupted research operations.

Methodology & Data Sources

Research findings are grounded in rigorous triangulation of primary and secondary data. Industry executives, laboratory leaders, and key opinion leaders contributed insights through interviews and surveys. Peer-reviewed publications, regulatory guidance, and public disclosures provided additional market intelligence, while an internal panel of scientific advisors validated segmentation and geographic analyses. This robust methodology ensures actionable and accurate recommendations.

Why This Report Matters

  • Empowers decision-makers to benchmark technology investments and tailor procurement strategies for maximum operational efficiency and ROI.
  • Provides segmented market perspectives, supporting strategic planning for technology adoption across geographies, applications, and user profiles.
  • Delivers supplier intelligence and partnership insights to enable more resilient and collaborative research environments.

Conclusion

Flow cytometry is playing a critical and evolving role in oncology and immunology research. Strategic insights provided here enable leaders to drive organizational agility, optimize investment, and align with a rapidly transforming technology landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of high-parameter spectral flow cytometry for multidimensional immune profiling in oncology
5.2. Adoption of artificial intelligence and machine learning algorithms for automated flow cytometry data analysis
5.3. Development of microfluidics-based portable flow cytometry devices for point-of-care cancer diagnostics
5.4. Expansion of immunophenotyping assays to support novel CAR T cell therapy monitoring in hematologic malignancies
5.5. Implementation of standardized workflows and reference datasets to improve reproducibility in multicenter immunology studies
5.6. Integration of flow cytometry with single-cell sequencing platforms for comprehensive tumor microenvironment characterization
5.7. Emergence of reagent-free flow cytometry techniques leveraging label-free detection for rapid cell analysis
5.8. Growth of automated sample preparation and data reporting software to streamline clinical flow cytometry operations
5.9. Increasing use of flow cytometry in multiplexed biomarker discovery for personalized oncology treatment strategies
5.10. Adoption of cloud-based data management solutions for secure sharing and collaborative analysis of flow cytometry data
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Flow Cytometry in Oncology & Immunology Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Cell Analyzers
8.2.1.1. Bench Top Analyzers
8.2.1.2. High Throughput Analyzers
8.2.2. Cell Sorters
8.2.2.1. Microfluidic Sorters
8.2.2.2. Nozzle Based Sorters
8.3. Reagents & Consumables
8.3.1. Consumables
8.3.1.1. Calibration Beads
8.3.1.2. Tubes & Plates
8.3.2. Reagents
8.3.2.1. Fluorochrome Antibodies
8.3.2.2. Kits
9. Flow Cytometry in Oncology & Immunology Market, by Technology
9.1. Introduction
9.2. Conventional Flow Cytometry
9.2.1. Multicolor Cytometry
9.2.1.1. Eight Or More Color Cytometry
9.2.1.2. Four Color Cytometry
9.2.2. Two Color Cytometry
9.3. Imaging Flow Cytometry
9.4. Mass Cytometry
10. Flow Cytometry in Oncology & Immunology Market, by Application
10.1. Introduction
10.2. Cell Therapy
10.2.1. CAR T Cell Therapy
10.2.2. Dendritic Cell Therapy
10.3. Clinical Diagnostics
10.3.1. Immunology Diagnostics
10.3.2. Oncology Diagnostics
10.4. Research
10.4.1. Immunology Research
10.4.2. Oncology Research
11. Flow Cytometry in Oncology & Immunology Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Contract Research Organizations
11.4. Hospitals & Clinics
11.5. Pharmaceutical Biotechnology Companies
11.6. Research Laboratories
12. Americas Flow Cytometry in Oncology & Immunology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Flow Cytometry in Oncology & Immunology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Flow Cytometry in Oncology & Immunology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Becton, Dickinson and Company
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Danaher Corporation
15.3.4. Merck KGaA
15.3.5. Sysmex Corporation
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. Agilent Technologies, Inc.
15.3.8. Miltenyi Biotec GmbH
15.3.9. Sony Biotechnology Inc.
15.3.10. Cytek Biosciences Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET: RESEARCHAI
FIGURE 24. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 25. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET: RESEARCHCONTACTS
FIGURE 26. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BENCH TOP ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY BENCH TOP ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HIGH THROUGHPUT ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HIGH THROUGHPUT ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MICROFLUIDIC SORTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MICROFLUIDIC SORTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY NOZZLE BASED SORTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY NOZZLE BASED SORTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CALIBRATION BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CALIBRATION BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TUBES & PLATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TUBES & PLATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLUOROCHROME ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FLUOROCHROME ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY EIGHT OR MORE COLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY EIGHT OR MORE COLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FOUR COLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY FOUR COLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TWO COLOR CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TWO COLOR CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMAGING FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CAR T CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY DENDRITIC CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY IMMUNOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ONCOLOGY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PHARMACEUTICAL BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 173. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 176. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 177. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 178. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 179. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 180. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 181. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 182. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 183. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 184. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 185. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 186. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 187. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 188. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 189. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 190. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 191. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 192. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 193. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 196. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 197. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 198. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 199. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 200. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 201. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. CANADA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 208. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 209. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 210. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 211. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 212. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 213. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 214. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 215. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 220. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 221. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 222. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 223. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 226. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 227. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 228. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 229. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 230. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 231. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. MEXICO FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONVENTIONAL FLOW CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY MULTICOLOR CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL THERAPY, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL ANALYZERS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CELL SORTERS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS & CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY CONSUMABLES, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA FLOW CYTOMETRY IN ONCOLOGY & IMMUNOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Flow Cytometry in Oncology & Immunology market report include:
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Miltenyi Biotec GmbH
  • Sony Biotechnology Inc.
  • Cytek Biosciences Inc.

Table Information